Opportunity overview
Supply of Hereditary Angioedema Branded Medicines to NHS Scotland: NP48925a Hereditary Angioedema Branded Medicines (Orladeyo®)
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
BioCryst UK Ltd
2 award entriesMatch pending…
- Contract value
- £1.6m
- Awarded
- Not supplied
- Contract signed
- 3 Apr 2025
- Status
- active
- Location
- Weybridge, UK, KT13 0NY, United Kingdom
View 2 award IDs
013175-2025-1, 020999-2025-1
Classification
- CPV33600000 — Pharmaceutical products
Lots
- The Framework Agreement is for the supply of berotralstat 150mg capsules (Orladeyo) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.Value not stated